Glaukos (GKOS) Non Operating Income (2014 - 2026)
Glaukos' (GKOS) quarterly Non Operating Income came in at $557000.0 in Q1 2026, down 80.51% year-on-year from $2.9 million in Q1 2025, and up 971.15% on a QoQ basis from $52000.0 in Q4 2025.
Glaukos (GKOS) Non Operating Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Non Operating Income data on file, last reported at $557000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income fell 80.51% year-over-year to $557000.0 in Q1 2026; TTM through Mar 2026 was $4.3 million, a 122.43% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 128.22% from the prior year.
- Non Operating Income for Q1 2026 stood at $557000.0, up from $52000.0 in the prior quarter.
- Over the last five years, Non Operating Income for GKOS reached as high as $3.4 million in Q3 2024 and fell as low as -$20.2 million in Q2 2024.
- Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$1.2 million in 2023.
- Across the five-year window, Non Operating Income plunged 512.96% in 2024 and jumped 304.87% in 2025, its largest moves.
- Year by year, Non Operating Income stood at $2.6 million in 2022, then fell by 25.97% to $1.9 million in 2023, then tumbled by 364.08% to -$5.0 million in 2024, then jumped by 101.03% to $52000.0 in 2025, then soared by 971.15% to $557000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $557000.0 in Q1 2026, $52000.0 in Q4 2025, and $368000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 557,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 557,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 368,000.00 |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Sep 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | -20.24 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | -2.40 Mn |
| Jun 30, 2023 | -3.30 Mn |
| Mar 31, 2023 | -1.23 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | -5.72 Mn |
| Jun 30, 2022 | -8.88 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | -4.37 Mn |
| Sep 30, 2021 | -4.59 Mn |
| Jun 30, 2021 | -3.05 Mn |